
51 - 200 employees
Founded 2003
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Summit Therapeutics, Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of innovative medicinal therapies aimed at improving quality of life for oncology patients. The company is particularly committed to addressing serious unmet medical needs through its lead investigational therapy, ivonescimab, a novel bispecific antibody designed to target both PD-1 and VEGF. Summit’s initiatives include ongoing Phase III clinical trials to evaluate ivonescimab's effectiveness in treating non-small cell lung cancer, highlighting their dedication to patient-centered care and technological advancement in the field of oncology.
🕒 August 25
Where this job comes from
Posted on Summit Therapeutics, Inc.'s careers page, not through a job board
First seen by Remote Rocketship August 25
Still open on Summit Therapeutics, Inc.'s site. Checked 7 hours ago.

51 - 200 employees
Founded 2003
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Summit Therapeutics, Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of innovative medicinal therapies aimed at improving quality of life for oncology patients. The company is particularly committed to addressing serious unmet medical needs through its lead investigational therapy, ivonescimab, a novel bispecific antibody designed to target both PD-1 and VEGF. Summit’s initiatives include ongoing Phase III clinical trials to evaluate ivonescimab's effectiveness in treating non-small cell lung cancer, highlighting their dedication to patient-centered care and technological advancement in the field of oncology.
• Interface with US population-based decision makers, including payers, health systems, clinical pathway organizations, P&T committees, and policy makers • Educate key stakeholders on the clinical, economic, and humanistic impact of ivonescimab • Inform formulary access, pathway/guideline decisions, and improve cancer patient outcomes • Provide objective, scientifically sound medical information using economic models, outcomes tools, educational programs, and collaborations • Partner compliantly with the commercial market access field team to facilitate access to ivonescimab • Independently cultivate and manage relationships with population-based decision makers • Collaborate with HEOR and market access teams on scientific engagement strategy • Provide clinical and healthcare economic information to payers and formulary decision-makers • Communicate clinical and economic information related to ivonescimab proactively and reactively • Capture and communicate stakeholder insights, evidence gaps, and collaboration opportunities internally • Contribute to content strategy development and execute aligned field tactics • Support inclusion of ivonescimab in clinical/payer pathways and treatment order sets while optimizing budget assessments • Collaborate with medical affairs, HEOR, market access, and other colleagues on account engagement plans • Present clinical, humanistic, and economic evidence and value propositions to payer audiences • Monitor market and payer needs and provide actionable recommendations for medical and market access strategy • Perform other assigned duties
• MD, PharmD, or PhD in Health Services Research, Health Economics, or related field • Minimum of 12+ years relevant experience in the healthcare industry • Minimum of 5+ years direct experience in pharmaceutical, managed care, or consulting industries • Previous experience in Oncology, preferably non-small cell lung cancer (NSCLC) • Previous experience in a field-based role • Strong understanding of the US healthcare system, market access landscape, and value-based decision makers • Experience analyzing healthcare data and utilizing real-world evidence (RWE) is a plus • Strong analytical capabilities • Excellent communication skills, including ability to communicate large amounts of scientific information clearly, concisely, and memorably • Ability to work collaboratively across diverse teams and manage multiple stakeholders • Ability to influence and collaborate to make a business impact • Ability to be proactive, enthusiastic, and goal oriented • Willingness to travel up to approximately 75% of the time, including overnight travel for internal and external meetings
• Bonus may be included in the total compensation package • Stock may be included in the total compensation package • Benefits may be included in the total compensation package • Other applicable variable compensation may be included • Equal opportunity employer committed to a diverse environment
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 August 25
IQVIA executive leading strategic clinical partnerships for mid-sized pharma customers. Driving global delivery, governance, financial performance, and customer growth across healthcare services.
🇺🇸 United States – Remote
💵 $165.4k - $460.8k / year
💰 $1G Post-IPO Debt on 2023-05
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🕒 August 25
Strategic services director leading North American Rail Solutions’ rail operations, growth strategies, compliance, and profitability. Managing teams, processes, customer relationships, and performance improvement.
🕒 August 24
Director leading U.S. gross-to-net forecasting, pricing strategy, and policy analytics for Otsuka’s pharmaceutical portfolio. Partnering with Finance, Market Access, Policy, and Global teams.
🕒 August 24
Creative Technology Director leading software and physical innovation projects at Deeplocal, an innovation studio creating brand experiences. Owning technical strategy, development, prototyping, and multidisciplinary project delivery.
🇺🇸 United States – Remote
💵 $145k - $190k / year
💰 $175k Convertible Note - deeplocal on 2010-07
⏰ Full Time
🔴 Lead
👔 Director
🕒 August 24
Scientific Director overseeing evidence-based oncology medical communications for pharmaceutical, biotech, and device clients. Leading scientific content strategy, development, and account execution.